Unknown

Dataset Information

Metagenomic Changes of Gut Microbiota following Treatment of Helicobacter pylori Infection with a Simplified Low-Dose Quadruple Therapy with Bismuth or Lactobacillus reuteri.


ABSTRACT:

Background

Probiotic supplementation to antibiotic regimens against Helicobacter pylori infection has been proposed to improve eradication rate and to decrease detrimental effects on gut microbiota.

Aims

To evaluate microbiota modifications due to a low-dose quadruple therapy with bismuth or Lactobacillus reuteri.

Methods

Forty-six patients infected with H. pylori were prospectively enrolled in a single-centre, randomized controlled trial to receive b.i.d. with meals for 10 days low-dose quadruple therapy consisting of rabeprazole 20 mg and bismuth (two capsules of Pylera® plus 250 mg each of tetracycline and metronidazole), or the same dose of rabeprazole and antibiotics plus Gastrus® (L. reuteri), one tablet twice-a-

SUBMITTER: Dore MP 

PROVIDER: S-EPMC9316840 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature